SANTA CLARA, Calif., July 17, 2023 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2023 after market close on Monday, August 7, 2023. Management will host…Read More
Related Posts
Rain Oncology Announces Collaborator Poster Presentation at the American Association for Cancer Research AACR Annual…
NEWARK, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. RAIN, ("Rain"), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule…
Latest News Scilex Holding Company Announces Postponement of Annual Businessfortnight
PALO ALTO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, "Scilex"), a subsidiary of Sorrento Therapeutics, Inc. (OTC Market: SRNEQ) ("Sorrento"), announced today that the Company's…
Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update
SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will report financial results and…
